Exploring Pharmacological Therapies for Fracture Risk Reduction in Adults with Osteogenesis Imperfecta
New research from the Brittle Bone Disorders Consortium (BBDC)

Exploring Pharmacological Therapies for Fracture Risk Reduction in Adults with Osteogenesis Imperfecta